Peregrine Pharmaceuticals reported $4.46M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Agenus AGEN:US $ 16.65M 298K
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Celldex Therapeutics CLDX:US $ 4.31M 185K
Chemocentryx CCXI:US $ 19.7M 3.44M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Eli Lilly And LLY:US $ 1.69B 109.7M
Flexion Therapeutics FLXN:US $ 27.41M 189K
GlaxoSmithKline GSK:LN 2.5B 183M
Immunogen IMGN:US $ 9.73M 481K
Intrexon XON:US $ 20M 1.3M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Kindred Biosciences KIN:US 5.87M 1.18M
Macrogenics MGNX:US $ 15.23M 198K
Mannkind MNKD:US $ 20.06M 2.64M
Merk MRK:US $ 2.25B 376M
Minerva Neurosciences NERV:US $ 3.44M 806.44K
Newlink Genetics NLNK:US 4.56M 604K
Novartis NOVN:VX 3.71B 190M
Novavax NVAX:US $ 73.16M 9.97M
Peregrine Pharmaceuticals PPHM:US $ 4.46M 595K
Repligen RGEN:US $ 44.34M 5.75M
Xencor XNCR:US $ 8.86M 637K